Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
(A joint stock company incorporated in the People's Republic of China with limited liability)
(Stock Code: 1339)
FIRST QUARTERLY REPORT OF 2021
This announcement is made by The People's Insurance Company (Group) of China Limited (the "Company") pursuant to the Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and Rules 13.09 and 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The financial data of the Company for the first quarter of 2021 are unaudited and have been prepared in accordance with the PRC Accounting Standards for Business Enterprises.
1. IMPORTANT INFORMATION
- The Board of Directors, the Board of Supervisors, the directors, the supervisors and the senior management of the Company undertake that the contents of this quarterly report are true, accurate and complete and that there is no false record, misleading statement or material omission in this quarterly report, and they severally and jointly accept responsibility for the contents of this quarterly report.
- The 2021 First Quarterly Report of the Company was considered and approved at the 27th meeting of the 3rd session of the Board of Directors of the Company on 28 April 2021, which 13 directors were required to attend and 13 of them attended in person.
- Mr. Luo Xi (Chairman of the Company), Mr. Wang Tingke (President in charge of accounting work) and Mr. Zhang Hongtao (Head of the Finance Department) warrant the truthfulness, accuracy and completeness of the financial statements contained in this quarterly report.
- The financial data contained in the 2021 First Quarterly Report of the Company are unaudited and have been prepared in accordance with the PRC Accounting Standards for Business Enterprises.
Note: Unless otherwise specified, the currencies in this report are all in RMB.
- 1 -
2. BASIC INFORMATION OF THE COMPANY 2.1 Key Financial Data
Unit: RMB million | |||
As of 31 | As of 31 | ||
March 2021 December 2020 | Change (%) | ||
Total Assets | 1,339,181 | 1,255,461 | 6.7 |
Equity attributable to shareholders of | |||
the parent company | 207,758 | 202,194 | 2.8 |
Net assets per share attributable to | |||
shareholders of the parent company | |||
(RMB/share) | 4.70 | 4.57 | 2.8 |
January to | January to | ||
March 2021 | March 2020 | Change (%) | |
Net cash flows generated from | |||
operating activities | 23,198 | 1,965 | 1,080.6 |
Operating income | 173,762 | 168,881 | 2.9 |
Net profit attributable to shareholders | |||
of the parent company | 10,034 | 7,061 | 42.1 |
Net profit attributable to shareholders | |||
of the parent company after | |||
deducting non-recurring items | 9,999 | 7,077 | 41.3 |
Basic earnings per share (RMB/share) | 0.23 | 0.16 | 42.1 |
Diluted earnings per share (RMB/ | |||
share) | 0.23 | 0.16 | 42.1 |
Basic earnings per share after | |||
deducting non-recurring items | |||
(RMB/share) | 0.23 | 0.16 | 41.3 |
Weighted average return on equity | Increase of | ||
(%) | 4.9 | 3.8 | 1.1 pts |
Weighted average return on equity | |||
after deducting non-recurring items | Increase of | ||
(%) | 4.9 | 3.8 | 1.1 pts |
Note: The percentage increase or decrease of basic earnings per share, diluted earnings per share and basic earnings per share after deducting non-recurring items is calculated based on the data before rounding off.
- 2 -
2.2 Non-recurring Items
Unit: RMB million | |||
January to | January to | ||
March 2021 | March 2020 | ||
Gains or losses from disposal of non-current assets | 42 | 19 | |
Government grants included in profit or loss | 12 | 12 | |
Net non-recurring items other than those | |||
mentioned above | 15 | (52) | |
Effect of income tax on non-recurring items | (20) | 1 | |
Attributable to non-controlling interests | (14) | 4 | |
Total | 35 | (16) | |
2.3 Solvency of the Group and Its Subsidiaries
Unit: RMB million | ||||||
As of 31 March 2021 | PICC Group | PICC P&C | PICC Life | PICC Health | ||
Core capital | 337,368 | 189,363 | 106,511 | 13,016 | ||
Actual capital | 399,723 | 217,345 | 119,345 | 16,569 | ||
Minimum capital | 128,790 | 71,606 | 46,122 | 8,516 | ||
Core solvency margin ratio (%) | 262 | 264 | 231 | 153 | ||
Comprehensive solvency margin | ||||||
ratio (%) | 310 | 304 | 259 | 195 | ||
Notes: | 1. | PICC Group means the Company and all of its subsidiaries; | ||||
2. | PICC P&C means PICC Property and Casualty Company Limited; | |||||
3. | PICC Life means PICC Life Insurance Company Limited; | |||||
4. | PICC Health means PICC Health Insurance Company Limited. |
- 3 -
2.4 Total Number of Shareholders, Shareholdings of the Top Ten Shareholders and Top Ten Shareholders not Subject to Selling Restrictions as at the End of the Reporting Period
Unit: Share | |||||||
Total number of shareholders (Shareholder) | A Share: 257,974; H Share: 5,643 | ||||||
Shareholdings of the Top Ten Shareholders | |||||||
Number of | The number | Pledged or frozen | |||||
shares held as | of shares held | shares | |||||
Name of shareholder | at the end of the | Proportion | subject to selling | Status of | Number | Class of | |
(in full name) | reporting period | (%) | restrictions | the shares | of shares | Shareholder | |
Ministry of Finance of the PRC | 26,906,570,608 | 60.84% | 26,906,570,608 | - | - | The State | |
HKSCC Nominees Limited | 8,702,517,698 | 19.68% | - | - | Foreign legal | ||
person | |||||||
National Council for Social Security | 6,313,368,327 | 14.28% | 2,989,618,956 | - | - | The State | |
Fund, PRC | |||||||
Hong Kong Securities Clearing | 47,954,061 | 0.11% | - | - | - | Foreign legal | |
Company Limited | person | ||||||
Beijing Hengzhaoweiye Investment | 20,607,653 | 0.05% | - | - | - | Domestic Non- | |
Company Limited | state-owned | ||||||
legal person | |||||||
Wang Ru | 13,982,890 | 0.03% | - | - | - | Domestic | |
natural person | |||||||
Industrial and Commercial Bank of | 12,795,077 | 0.03% | - | - | - | Others | |
China-Shanghai 50 Transactional | |||||||
Open Index Securities Investment | |||||||
Fund | |||||||
Li Shaofu | 12,150,000 | 0.03% | - | - | - | Domestic | |
natural person | |||||||
CITIC Securities Company Limited | 9,912,088 | 0.02% | - | - | - | Domestic Non- | |
state-owned | |||||||
legal person | |||||||
Huo Wenliang | 9,774,871 | 0.02% | - | - | - | Domestic natural | |
person | |||||||
- 4 -
Shareholdings of the Top Ten Shareholders Not Subject to Selling Restrictions
Number of shares held | |||
not subject to selling | Class and number of shares | ||
Name of shareholder | restrictions | Class | Number |
HKSCC Nominees Limited | 8,702,517,698 | H Share | 8,702,517,698 |
National Council for Social Security | 3,323,749,371 | A Share | 3,323,749,371 |
Fund, PRC | |||
Hong Kong Securities Clearing | 47,954,061 | A Share | 47,954,061 |
Company Limited | |||
Beijing Hengzhaoweiye Investment | 20,607,653 | A Share | 20,607,653 |
Company Limited | |||
Wang Ru | 13,982,890 | A Share | 13,982,890 |
Industrial and Commercial Bank of | 12,795,077 | A Share | 12,795,077 |
China-Shanghai 50 Transactional Open | |||
Index Securities Investment Fund | |||
Li Shaofu | |||
CITIC Securities Company Limited | |||
Huo Wenliang | |||
Li Mahao | |||
Details of the above shareholders who |
are connected to each other or acting in concert
3 | QUARTERLY BUSINESS ANALYSIS | ||||
3.1 Key Financial Indicators | |||||
Unit: RMB million | |||||
January to | January to | ||||
March 2021 | March 2020 | Change (%) | |||
Gross written premiums | 204,754 | 194,177 | 5.4 | ||
Profit before tax | 16,172 | 12,070 | 34.0 | ||
Net profit | 13,844 | 9,876 | 40.2 | ||
Net profit attributable to shareholders of | |||||
the parent company | 10,034 | 7,061 | 42.1 | ||
Basic earnings per share (RMB/share) | 0.23 | 0.16 | 42.1 | ||
Weighted average return on equity (%) | 4.9 | 3.8 | Increase of 1.1 pts | ||
As of | As of | ||||
31 March | 31 December | ||||
2021 | 2020 | Change (%) | |||
Total assets | 1,339,181 | 1,255,461 | 6.7 | ||
Total liabilities | 1,058,117 | 982,325 | 7.7 | ||
Total equity | 281,064 | 273,136 | 2.9 | ||
Net assets per share attributable to | |||||
shareholders of the parent company | |||||
(RMB/share) | 4.70 | 4.57 | 2.8 | ||
Gearing ratio (%) | 79.0 | 78.2 | Increase of 0.8 pt | ||
In the first quarter of 2021, the Group1 firmly kept in mind the initial mission of serving the people, carried out "To be Prominent Strategy", strengthened responsibility, maintained a stable, progressive, and positive development trend in the core businesses. Its profitability increased significantly, and the performance of cash flows from operating activities was excellent. The group has achieved satisfactory results in the transformation to high-quality development. In the first quarter of 2021, the gross written premiums of the Group amounted to RMB204,754 million, representing a period-on-period increase of 5.4%. The net profit amounted to RMB13,844 million, representing a period-on-period increase of 40.2%. The net profit attributable to shareholders of the parent company amounted to RMB10,034 million, representing a period-on-period increase of 42.1%. The net profit attributable to shareholders of the parent company after deducting non-recurring items amounted to RMB9,999 million, representing a period-on-period increase of 41.3%. The earnings per share amounted to RMB0.23, representing a period-on-period increase of 42.1%. The weighted average return on equity was 4.9%, representing a period-on-period increase of 1.1 percentage points. The net cash flow generated from operating activities amounted to RMB23,198 million, representing a significantly increase compared with the same period of last year.
1 The Group means the Company and all of its subsidiaries.
- 6 -
The Group further boosted its capital. As of 31 March 2021, the total equity of the Group was RMB281,064 million, representing an increase of 2.9% as compared to the beginning of the year, the net assets per share attributable to shareholders of the parent company was RMB4.70, representing an increase of 2.8% as compared to the beginning of the year.
3.2 Insurance Business
3.2.1 PICC P&C
In the first quarter of 2021, PICC P&C fully implemented "To be Prominent Strategy" of the Group, consistently upheld a customer-centric concept and concentrated on the four main themes consisting of "focusing on main business, striving for excellence, emphasizing on competency and providing comprehensive service", proactively responded to the comprehensive reform of motor vehicle insurance, optimised business structure and resource allocation, strictly controlled business risks, promoted the development through reform and innovation and achieved a good start. During the reporting period, PICC P&C1 achieved original premiums income of RMB135,552 million, representing a period-on-period increase of 6.2%. The claim ratio was 70.3%, representing a period-on-period increase of 4.0 percentage points. The expense ratio was 25.4%, representing a period-on-period decrease of 5.4 percentage points. The combined ratio was 95.7%, representing a period-on-period decrease of 1.4 percentage points. The net profit amounted to RMB8,942 million, representing a period-on-period increase of 40.7%.
The original premiums income by type from PICC P&C for the above periods indicated as follows:
Unit: RMB million | ||||
January to | January to | |||
March 2021 | March 2020 | Change (%) | ||
Motor vehicle insurance | 57,503 | 61,660 | (6.7) | |
Accidental injury and health | ||||
insurance | 43,646 | 34,805 | 25.4 | |
Agricultural insurance | 12,196 | 9,766 | 24.9 | |
Liability insurance | 9,784 | 8,213 | 19.1 | |
Commercial property insurance | 5,266 | 4,859 | 8.4 | |
Credit insurance | 490 | 2,497 | (80.4) | |
Cargo insurance | 1,257 | 1,039 | 21.0 | |
Other P&C insurance | 5,410 | 4,804 | 12.6 | |
Total | 135,552 | 127,643 | 6.2 | |
1 The data is from the individual statement of PICC P&C as the parent company.
- 7 -
3.2.2 PICC Life
In the first quarter of 2021, PICC Life thoroughly implemented the Group's "To be Prominent Strategy", put more efforts into innovation and reform, improved product structure, vigorously promoted team-building and the development of value- based regular premium business, strictly controlled risks, reinforced the foundation of development and strengthened value-oriented, which led to further improved profitability. During the reporting period, PICC Life achieved original premiums income of RMB50,660 million, representing a period-on-period decrease of 5.4%. The regular original premiums income amounted to RMB40,737 million, representing a period-on-period increase of 6.5%. The first-year regular total written premiums with the paid period of more than ten years amounted to RMB1,581 million. The net profit was RMB3,290 million, representing a period-on-period increase of 15.6%.
The original premiums income by type from PICC Life for the above periods indicated as follows:
Unit: RMB million | ||||
January to | January to | |||
March 2021 | March 2020 | Change (%) | ||
First-year business of long-term | ||||
insurance | 21,527 | 26,128 | (17.6) | |
Single premiums | 8,868 | 14,331 | (38.1) | |
First-year regular premiums | 12,659 | 11,797 | 7.3 | |
Renewal business | 28,078 | 26,459 | 6.1 | |
Short-term insurance | 1,055 | 992 | 6.4 | |
Total | 50,660 | 53,579 | (5.4) | |
- 8 -
3.2.3 PICC Health
In the first quarter of 2021, PICC Health extensively carried out the Group's "To be Prominent Strategy", adhered to the direction of serving people's health, highlighted the two functions of "protecting from health risks and providing healthcare services", concentrated on the three key words of "Progress, Breakthrough, and Reform", promoted business growth, strengthened corporation's characteristics, enhanced sales' quality and efficiency, steadily promoted the transformation of business model. PICC Health accelerated the high-quality development in the strategy of serving "Healthy China" and constructing the national multi-level medical security system and realised the relatively rapid growth in business, which indicates the overall business of PICC Health will continue to achieve sustained growth. During the reporting period, PICC Health achieved original premiums income of RMB17,190 million, representing a period-on-period increase of 37.0%. The net profit amounted to RMB141 million, representing a period-on-period increase of 56.7%.
The original premiums income by type from PICC Health for the above periods indicated as follows:
Unit: RMB million | ||||
January to | January to | |||
March 2021 | March 2020 | Change (%) | ||
First-year business of long-term | ||||
insurance | 7,040 | 3,627 | 94.1 | |
Single premiums | 5,122 | 1,240 | 313.1 | |
First-year regular premiums | 1,918 | 2,387 | (19.6) | |
Renewal business | 3,585 | 2,004 | 78.9 | |
Short-term insurance | 6,565 | 6,917 | (5.1) | |
Total | 17,190 | 12,548 | 37.0 | |
3.3 Asset Management Business
In the first quarter of 2021, the asset management segment of the Group actively served for the new development pattern of national "Dual Circulation", implemented requirements of the Group's "To be Prominent Strategy", strengthened market trend research, adjusted asset allocation dynamically, made the investment yield well, and prevented investment risks effectively. In terms of bond investment, the asset management segment chose optimal allocation time, grasped investment opportunities, and never chase the high income at the expense of credit sinking. In terms of equity investment, it actively seized investment opportunities of industry and individual stock, optimised the position structure constantly, and achieved robust investment performance.
- 9 -
4. IMPORTANT INFORMATION
4.1 Particulars of and Reasons for Material Changes in Major Accounting Items and Financial Indicators of the Company
4.1.1 Changes in key financial indicators and the reasons
Unit: RMB million | ||||
As of 31 | As of 31 | |||
Key financial | March | December | Change | Reasons of |
indicators | 2021 | 2020 | (%) | major changes |
Total assets | 1,339,181 | 1,255,461 | 6.7 | Growth in |
insurance | ||||
business | ||||
Total liabilities | 1,058,117 | 982,325 | 7.7 | Increase in |
insurance | ||||
reserves | ||||
Equity attributable to | 207,758 | 202,194 | 2.8 | Increase in net |
shareholders of the | profits | |||
parent company | ||||
Unit: RMB million | ||||
Key financial | January to | January to | Change | Reasons of major |
indicators | March 2021 | March 2020 | (%) | changes |
Operating income | 173,762 | 168,881 | 2.9 | Growth in |
insurance | ||||
business and | ||||
increase in | ||||
investment | ||||
income | ||||
Net profit attributable | 10,034 | 7,061 | 42.1 | Increase in |
to the shareholders of | investment | |||
the parent company | income | |||
- 10 -
4.1.2 Material changes in major financial items and analysis | |||||
Unit: RMB million | |||||
As of 31 | As of 31 | ||||
March | December | Change | Reasons of major | ||
Items in Balance Sheet | 2021 | 2020 | (%) | changes | |
Premiums receivable | 85,612 | 36,775 | 132.8 | Growth in scale | |
of government | |||||
coordinating | |||||
business | |||||
Receivables from | 22,717 | 15,578 | 45.8 | Affected by | |
reinsurers | increase of | ||||
premiums ceded | |||||
and reinsurance | |||||
settlement cycle | |||||
Premiums received in | 13,177 | 24,048 | (45.2) | Transformation | |
advance | of prepaid | ||||
premiums | |||||
to received | |||||
premiums | |||||
Payables to reinsurers | 31,093 | 21,296 | 46.0 | Affected by | |
reinsurance | |||||
settlement cycle | |||||
Policyholders' dividend | 5,477 | 4,096 | 33.7 | Increase in policy | |
payable | dividend | ||||
Deferred tax liabilities | 271 | 1,449 | (81.3) | Fluctuation in | |
capital market | |||||
- 11 -
Items in | January to | January to | Change | Unit: RMB million | |
income statement | March 2021 | March 2020 | (%) Reasons of major changes | ||
Reinsurance premiums | 1,300 | 359 | 262.1 | Increase in overseas | |
assumed | 36,017 | reinsurance business | |||
Change in unearned | 27,683 | 30.1 | Increase in insurance | ||
premium reserves | business and decline in | ||||
17,995 | policy acquisition cost ratio | ||||
Investment income | 13,165 | 36.7 | Increase in the bid-ask spread | ||
387 | of financial assets | ||||
Fair value losses | 57 | 578.9 | Fluctuation in capital market | ||
Exchange gains | 90 | 232 | (61.2) | Fluctuation in exchange rate | |
Gains on disposal of assets | 42 | 22 | 90.9 | Increase in disposal of assets | |
Other operating income | 798 | 594 | 34.3 | Increase in rental income and | |
6,622 | management income | ||||
Surrenders | 34,216 | (80.6) | Adjustment of business | ||
structure and significant | |||||
reduction of surrenders | |||||
compared with the same | |||||
78,030 | period of last year | ||||
Gross claims paid | 59,062 | 32.1 | Achieving faster claim | ||
5,718 | settlement | ||||
Paid losses recoverable | 3,821 | 49.6 | Achieving faster claim | ||
from reinsurers | settlement and increase in | ||||
41,166 | ceded scale | ||||
Change in insurance | 25,863 | 59.2 | Decrease in the surrender | ||
contract liability reserves | value of life insurance | ||||
compared with the same | |||||
Reinsurers' share of | (1,352) | period of last year | |||
(360) | 275.6 | Decrease in original | |||
insurance contract | insurance outstanding | ||||
liability reserves | claim reserves compared | ||||
with the same period | |||||
of last year, leading to | |||||
corresponding increase | |||||
in the reinsurers' share of | |||||
insurance contract liability | |||||
371 | reserves | ||||
Reinsurance expenses | 109 | 240.4 | Increase in reinsurance | ||
334 | business | ||||
Impairment losses | 618 | (46.0) | Improvement of premiums | ||
receivable and reduction of | |||||
16,177 | bad debts loss | ||||
Operating profit | 12,121 | 33.5 | Affected by above mentioned | ||
Non-operating expenses | 38 | 80 | (52.5) | Reduction of donation | |
16,172 | expenditure | ||||
Profit before tax | 12,070 | 34.0 | Affected by above mentioned | ||
Net profit | 13,844 | 9,876 | 40.2 | Affected by above mentioned | |
Other comprehensive | (5,916) | (3,085) | 91.8 | Fluctuation in fair value of | |
income, net of tax | available-for-sale financial | ||||
assets | |||||
4.2 Explanation and Analysis of Significant Events and Their Impacts and Solutions
□Applicable √Not applicable
- 12 -
-
Undertakings Were Not Implemented in Due Time During the Reporting Period
□Applicable √Not applicable - Warning of Projection on Cumulative Net Profit for the Period from the Beginning of the Year to the End of the Next Reporting Period to be at a Loss or Expected to Have Material Changes as Compared to the Corresponding Period of Last Year and Its Explanation
□Applicable √Not applicable
- 13 -
5. APPENDIX
5.1 Consolidated Statement of Financial Position and Statement of Financial Position of the Company as at 31 March 2021 and 31 December 2020
Consolidated Statement of Financial Position As at 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
31 March | 31 December | ||
2021 | 2020 | ||
(Unaudited) | (Audited) | ||
ASSETS | |||
Cash and bank balances | 20,982 | 24,104 | |
Financial assets at fair value through profit or loss | 41,272 | 33,433 | |
Financial assets purchased under resale agreements | 55,307 | 55,081 | |
Premiums receivable | 85,612 | 36,775 | |
Receivables from reinsurers | 22,717 | 15,578 | |
Reinsurers' share of unearned premium reserves | 14,811 | 12,202 | |
Reinsurers' share of outstanding claim reserves | 16,522 | 18,192 | |
Reinsurers' share of life insurance reserves | 27 | 25 | |
Reinsurers' share of long-term health insurance | |||
reserves | 4,388 | 4,072 | |
Policy loans | 5,611 | 5,295 | |
Other receivables | 15,400 | 13,893 | |
Term deposits | 89,807 | 89,016 | |
Available-for-sale financial assets | 399,152 | 379,312 | |
Held-to-maturity investments | 183,524 | 181,199 | |
Investments classified as loans and receivables | 163,855 | 171,307 | |
Long-term equity investments | 127,880 | 124,840 | |
Restricted statutory deposits | 12,994 | 12,994 | |
Investment properties | 13,035 | 13,246 | |
Fixed assets | 32,912 | 33,183 | |
Right-of-use assets | 2,878 | 2,942 | |
Intangible assets | 7,916 | 8,123 | |
Deferred tax assets | 9,734 | 8,491 | |
Other assets | 12,845 | 12,158 | |
TOTAL ASSETS | 1,339,181 | 1,255,461 | |
- 14 -
31 March | 31 December | ||
2021 | 2020 | ||
(Unaudited) | (Audited) | ||
LIABILITIES AND EQUITY | |||
LIABILITIES | |||
Securities sold under agreements to repurchase | 78,410 | 85,826 | |
Premiums received in advance | 13,177 | 24,048 | |
Handling charges and commission payable | 9,251 | 8,177 | |
Payables to reinsurers | 31,093 | 21,296 | |
Salaries and staff welfare payables | 22,144 | 21,671 | |
Tax payable | 10,000 | 8,579 | |
Claims payable | 9,661 | 12,493 | |
Policyholders' dividend payable | 5,477 | 4,096 | |
Other payables | 17,577 | 17,167 | |
Policyholders' deposits | 41,266 | 39,338 | |
Unearned premium reserves | 199,488 | 160,862 | |
Outstanding claim reserves | 161,181 | 162,022 | |
Life insurance reserves | 342,547 | 303,046 | |
Long-term health insurance reserves | 48,113 | 45,031 | |
Premiums reserve | 3,095 | 2,594 | |
Bonds payable | 57,008 | 56,960 | |
Lease liabilities | 2,932 | 2,792 | |
Deferred tax liabilities | 271 | 1,449 | |
Other liabilities | 5,426 | 4,878 | |
TOTAL LIABILITIES | 1,058,117 | 982,325 | |
- 15 -
31 March | 31 December | ||
2021 | 2020 | ||
(Unaudited) | (Audited) | ||
EQUITY | |||
Issued capital | 44,224 | 44,224 | |
Share premium account | 7,545 | 7,545 | |
Other comprehensive income | 12,998 | 17,468 | |
Surplus reserve | 13,319 | 13,319 | |
General risk reserve | 13,781 | 13,772 | |
Catastrophic loss reserve | 793 | 793 | |
Retained profits | 115,098 | 105,073 | |
Equity attributable to equity holders of the Company | 207,758 | 202,194 | |
Non-controlling interests | 73,306 | 70,942 | |
TOTAL EQUITY | 281,064 | 273,136 | |
TOTAL LIABILITIES AND EQUITY | 1,339,181 | 1,255,461 | |
- 16 -
Statement of Financial Position of The Company
As at 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
31 March | 31 December | ||
2021 | 2020 | ||
(Unaudited) | (Audited) | ||
ASSETS | |||
Cash and bank balances | 694 | 489 | |
Financial assets at fair value through profit or loss | 676 | 740 | |
Financial assets purchased under resale agreements | 232 | 280 | |
Other receivables | 298 | 218 | |
Term deposit | 4,463 | 4,462 | |
Available-for-sale financial assets | 12,783 | 12,126 | |
Investments classified as loans and receivables | 7,248 | 7,248 | |
Long term equity investments | 91,126 | 91,042 | |
Investment properties | 2,542 | 2,542 | |
Fixed assets | 2,768 | 2,790 | |
Intangible assets | 88 | 85 | |
Other assets | 80 | 66 | |
TOTAL ASSETS | 122,998 | 122,088 | |
- 17 -
31 March | 31 December | ||
2021 | 2020 | ||
(Unaudited) | (Audited) | ||
LIABILITIES AND EQUITY | |||
LIABILITIES | |||
Securities sold under agreements to repurchase | 123 | 30 | |
Salaries and staff welfare payables | 3,539 | 3,593 | |
Tax payable | 25 | 12 | |
Other payables | 442 | 384 | |
Bonds payable | 17,988 | 17,987 | |
Other liabilities | 872 | 647 | |
TOTAL LIABILITIES | 22,989 | 22,653 | |
EQUITY | |||
Issued capital | 44,224 | 44,224 | |
Share premium account | 35,578 | 35,578 | |
Other comprehensive income | 1,280 | 908 | |
Surplus reserve | 13,319 | 13,319 | |
Retained profits | 5,608 | 5,406 | |
TOTAL EQUITY | 100,009 | 99,435 | |
TOTAL LIABILITIES AND EQUITY | 122,998 | 122,088 | |
- 18 -
5.2 Consolidated Income Statement and Income Statement of the Company for the Three Months Ended 31 March 2021 and for the Three Months Ended 31 March 2020
Consolidated Income Statement
For the three months ended 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
OPERATING INCOME | 173,762 | 168,881 | ||
Net earned premiums | 155,091 | 154,814 | ||
Gross written premiums | 204,754 | 194,177 | ||
Included: Reinsurance premiums assumed | 1,300 | 359 | ||
Less: Premiums ceded to reinsurers | (13,646) | (11,680) | ||
Change in unearned premium reserves | (36,017) | (27,683) | ||
Investment income | 17,995 | 13,165 | ||
Included: Share of profits and losses of | ||||
associates and joint ventures | 2,643 | 2,203 | ||
Fair value losses | (387) | (57) | ||
Exchange gains | 90 | 232 | ||
Gains on disposal of assets | 42 | 22 | ||
Other income | 133 | 111 | ||
Other operating income | 798 | 594 | ||
OPERATING EXPENSES | 157,585 | 156,760 | ||
Surrenders | 6,622 | 34,216 | ||
Gross claims paid | 78,030 | 59,062 | ||
Less: Paid losses recoverable from reinsurers | (5,718) | (3,821) | ||
Change in insurance contract liability reserves | 41,166 | 25,863 | ||
Less: Reinsurers' share of insurance contract liability | ||||
reserves | 1,352 | 360 | ||
Change in premium reserve | 363 | 291 | ||
Interest expenses credited to policyholders' deposits | 1,995 | 1,808 | ||
Reinsurance expenses | 371 | 109 | ||
Tax and other surcharges | 411 | 490 | ||
Handling charges and commissions | 14,744 | 17,407 | ||
General and administrative expenses | 19,438 | 21,656 | ||
Less: Net reinsurance commission income | (3,421) | (2,949) | ||
Other operating costs | 1,898 | 1,650 | ||
Impairment losses | 334 | 618 |
- 19 -
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
OPERATING PROFIT | 16,177 | 12,121 | ||
Add: Non-operating income | 33 | 29 | ||
Less: Non-operating expenses | (38) | (80) | ||
PROFIT BEFORE TAX | 16,172 | 12,070 | ||
Less: Income tax expense | (2,328) | (2,194) | ||
NET PROFIT | 13,844 | 9,876 | ||
By continuing operations: | ||||
Net profit from continuing operations | 13,844 | 9,876 | ||
By ownership: | ||||
1. Net profit attributable to equity holders of the | ||||
Company | 10,034 | 7,061 | ||
2. Net profit attributable to non-controlling interests | 3,810 | 2,815 | ||
OTHER COMPREHENSIVE INCOME FOR THE | ||||
YEAR, NET OF TAX | ||||
Other comprehensive income attributable to equity | ||||
holders of the company, net of tax | (4,470) | (2,364) | ||
OTHER COMPREHENSIVE INCOME THAT MAY | ||||
BE RECLASSIFIED TO PROFIT OR LOSS: | ||||
Fair value losses of available-for-sale financial assets | (4,408) | (2,425) | ||
Portion of fair value changes attributable to | ||||
participating policyholders | (334) | - | ||
Other comprehensive income that may be reclassified | ||||
to profit or loss under the equity method | 225 | 39 | ||
Exchange differences arising on translation of foreign | ||||
operations | 9 | 22 | ||
OTHER COMPREHENSIVE INCOME THAT WILL | ||||
NOT BE RECLASSIFIED TO PROFIT OR LOSS | ||||
Other comprehensive income that cannot be | ||||
reclassified to profit or loss under the equity method | 38 | - | ||
Other comprehensive income attributable to non- | ||||
controlling interests, net of tax | (1,446) | (721) | ||
TOTAL | (5,916) | (3,085) | ||
- 20 -
Three months | Three months | ||
ended | ended | ||
31 March 2021 | 31 March 2020 | ||
(Unaudited) | (Unaudited) | ||
TOTAL COMPREHENSIVE INCOME | 7,928 | 6,791 | |
Attributable to equity holders of the Company | 5,564 | 4,697 | |
Attributable to non-controlling interests | 2,364 | 2,094 | |
EARNINGS PER SHARE (in RMB Yuan) | |||
- Basic | 0.23 | 0.16 | |
Note: The Group had no potential ordinary shares in issue during the three months ended 31 March 2021 and the three months ended 31 March 2020.
- 21 -
Income Statement of The Company
For the three months ended 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
OPERATING INCOME | 495 | 409 | ||
Investment income | 458 | 335 | ||
Included: Share of profits and losses of | ||||
associates | 84 | 82 | ||
Fair value losses | (30) | (35) | ||
Exchange gains | 3 | 30 | ||
Other operating income | 64 | 79 | ||
OPERATING EXPENSES | 427 | 427 | ||
Tax and other surcharges | 4 | 3 | ||
General and administrative expenses | 158 | 163 | ||
Other operating costs | 250 | 254 | ||
Impairment losses | 15 | 7 | ||
OPERATING PROFIT | 68 | (18) | ||
Add: Non-operating income | - | - | ||
Less: Non-operating expenses | - | - | ||
PROFIT BEFORE TAX | 68 | (18) | ||
Less: Income tax credit/(expense) | 134 | (245) | ||
NET PROFIT | 202 | (263) | ||
- 22 -
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
OTHER COMPREHENSIVE INCOME | ||||
OTHER COMPREHENSIVE INCOME | ||||
THAT MAY BE RECLASSIFIED | ||||
SUBSEQUENTLY TO PROFIT OR LOSS: | ||||
Fair value gains/(losses) of available-for-sale | ||||
financial assets | 372 | (684) | ||
OTHER COMPREHENSIVE INCOME | ||||
THAT WILL NOT BE RECLASSIFIED TO | ||||
PROFIT OR LOSS | ||||
Remeasurement of the variation of defined | ||||
benefit plans | - | - | ||
OTHER COMPREHENSIVE INCOME, | ||||
NET OF TAX | 372 | (684) | ||
TOTAL COMPREHENSIVE INCOME | 574 | (947) | ||
- 23 -
5.3 Consolidated Statement of Cash Flow and Statement of Cash Flow of the Company for the Three Months Ended 31 March 2021 and for the Three Months Ended 31 March 2020
Consolidated Statement of Cash Flows For the three months ended 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
CASH FLOWS FROM OPERATING | ||||
ACTIVITIES | ||||
Cash received from premiums under direct | ||||
insurance contracts | 148,828 | 145,215 | ||
Increase from policyholders' deposits | 1,660 | - | ||
Other cash inflows from operating activities | 2,810 | 4,428 | ||
Cash inflows from operating activities | 153,298 | 149,643 | ||
Cash paid for claims payments under direct | ||||
insurance contracts | (79,766) | (59,098) | ||
Decrease from policyholders' deposits | - | (3,621) | ||
Cash paid for reinsurance, net | (1,471) | (1,251) | ||
Handling charges and commissions paid | (13,995) | (16,746) | ||
Interest paid to policyholders' deposits | (614) | (944) | ||
Payment to and on behalf of staff | (13,209) | (12,203) | ||
Taxes and surcharges paid | (3,710) | (4,777) | ||
Other cash outflows for operating activities | (17,335) | (49,038) | ||
Cash outflows for operating activities | (130,100) | (147,678) | ||
Net cash flows generated from operating activities | 23,198 | 1,965 | ||
- 24 -
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
CASH FLOWS FROM INVESTING | ||||
ACTIVITIES | ||||
Proceeds from disposals of investments | 57,676 | 105,093 | ||
Cash received from investment income | 13,793 | 10,786 | ||
Proceeds from disposals of fixed assets, intangible | ||||
assets and other long term assets | 302 | 58 | ||
Cash inflows from investing activities | 71,771 | 115,937 | ||
Payment for purchases of investments | (87,861) | (129,104) | ||
Net increase in policy loans | (316) | (73) | ||
Payment for purchases of fixed assets, intangible | ||||
assets and other long term assets | (625) | (1,939) | ||
Other cash outflows for investing activities | (59) | (51) | ||
Cash outflows for investing activities | (88,861) | (131,167) | ||
Net cash flows used in investing activities | (17,090) | (15,230) | ||
- 25 -
Three months | Three months | ||||
ended | ended | ||||
31 March 2021 | 31 March 2020 | ||||
(Unaudited) | (Unaudited) | ||||
CASH FLOWS FROM FINANCING | |||||
ACTIVITIES | |||||
Cash inflows from debt issuance | - | 8,000 | |||
Cash inflows from financing activities | - | 8,000 | |||
Repayment of bank borrowings | (4) | - | |||
Repayment of lease liabilities | (422) | (239) | |||
Cash paid for distribution of dividends, profits or | |||||
interests | (675) | (305) | |||
Other cash outflows for financing activities | (7,416) | (2,952) | |||
Cash outflows for financing activities | (8,517) | (3,496) | |||
Net cash flows (used in)/generated from financing | |||||
activities | (8,517) | 4,504 | |||
NET FOREIGN EXCHANGE DIFFERENCES | (12) | 27 | |||
NET DECREASE IN CASH AND CASH | |||||
EQUIVALENTS | (2,421) | (8,734) | |||
Cash and cash equivalents at beginning of the | |||||
period | 78,209 | 76,984 | |||
CASH AND CASH EQUIVALENTS AT END | |||||
OF THE PERIOD | 75,788 | 68,250 | |||
- 26 -
Statement of Cash Flow of The Company For the three months ended 31 March 2021
(Amounts in millions of Renminbi, unless otherwise stated)
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
CASH FLOWS FROM OPERATING | ||||
ACTIVITIES | ||||
Other cash inflows from operating activities | 153 | 79 | ||
Cash inflows from operating activities | 153 | 79 | ||
Payment to and on behalf of staff | (163) | (149) | ||
Taxes and surcharges paid | (6) | (1) | ||
Other cash outflows for operating activities | (43) | (72) | ||
Cash outflows for operating activities | (212) | (222) | ||
Net cash flows used in operating activities | (59) | (143) | ||
CASH FLOWS FROM INVESTING | ||||
ACTIVITIES | ||||
Proceeds from disposals of investments | 2,137 | 2,467 | ||
Investment income received | 205 | 165 | ||
Net cash inflow on disposal of a subsidiary | - | 236 | ||
Cash inflows from investing activities | 2,342 | 2,868 | ||
Payment for purchases of investments | (2,202) | (4,937) | ||
Payment for purchases of fixed assets, intangible | ||||
assets and other long term assets | (13) | (1) | ||
Other cash outflows for investing activities | (4) | (2) | ||
Cash outflows for investing activities | (2,219) | (4,940) | ||
Net cash flows generated from/(used in) investing | ||||
activities | 123 | (2,072) | ||
- 27 -
Three months | Three months | |||
ended | ended | |||
31 March 2021 | 31 March 2020 | |||
(Unaudited) | (Unaudited) | |||
CASH FLOWS FROM FINANCING | ||||
ACTIVITIES | ||||
Net cash inflow from securities sold under | ||||
agreements to repurchase | 93 | 205 | ||
Cash inflows from financing activities | 93 | 205 | ||
Interested paid | (2) | (2) | ||
Cash outflows for financing activities | (2) | (2) | ||
Net cash flows generated from financing activities | 91 | 203 | ||
NET FOREIGN EXCHANGE DIFFERENCES | 2 | 31 | ||
NET INCREASE/(DECREASE) IN CASH AND | ||||
CASH EQUIVALENTS | 157 | (1,981) | ||
Cash and cash equivalents at beginning of the | ||||
period | 768 | 3,003 | ||
CASH AND CASH EQUIVALENTS AT END | ||||
OF THE PERIOD | 925 | 1,022 | ||
By Order of the Board
The People's Insurance Company (Group) of China Limited
Luo Xi
Chairman
Beijing, the PRC, 28 April 2021
As at the date of this announcement, the executive directors of the Company are Mr. Luo Xi, Mr. Wang Tingke, Mr. Xie Yiqun and Mr. Li Zhuyong, the non-executive directors are Mr. Wang Qingjian, Mr. Miao Fusheng, Mr. Wang Shaoqun, Ms. Cheng Yuqin and Mr. Wang Zhibin, and the independent non- executive directors are Mr. Shiu Sin Por, Mr. Ko Wing Man, Mr. Lin Yixiang and Mr. Chen Wuzhao.
- 28 -
Attachments
- Original document
- Permalink
Disclaimer
PICC - The People's Insurance Company (Group) of China Ltd. published this content on 28 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2021 09:44:03 UTC.